REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 201 filers reported holding REATA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $353,000 | +99.4% | 3,462 | +77.4% | 0.00% | – |
Q1 2023 | $177,000 | -0.6% | 1,951 | -58.3% | 0.00% | – |
Q4 2022 | $178,000 | +790.0% | 4,677 | +464.2% | 0.00% | – |
Q3 2022 | $20,000 | +122.2% | 829 | +185.9% | 0.00% | – |
Q2 2022 | $9,000 | -83.9% | 290 | -83.0% | 0.00% | – |
Q1 2022 | $56,000 | -62.2% | 1,708 | -69.5% | 0.00% | – |
Q4 2021 | $148,000 | -51.5% | 5,605 | +84.6% | 0.00% | – |
Q3 2021 | $305,000 | +12.5% | 3,037 | +58.9% | 0.00% | – |
Q2 2021 | $271,000 | -81.5% | 1,911 | -87.0% | 0.00% | – |
Q1 2021 | $1,462,000 | +2658.5% | 14,667 | +3318.9% | 0.00% | – |
Q4 2020 | $53,000 | +140.9% | 429 | +90.7% | 0.00% | – |
Q3 2020 | $22,000 | -98.9% | 225 | -98.3% | 0.00% | -100.0% |
Q2 2020 | $2,040,000 | +100.8% | 13,074 | +85.7% | 0.00% | – |
Q1 2020 | $1,016,000 | +936.7% | 7,039 | +1375.7% | 0.00% | – |
Q4 2019 | $98,000 | +512.5% | 477 | +138.5% | 0.00% | – |
Q3 2019 | $16,000 | -57.9% | 200 | -50.5% | 0.00% | – |
Q2 2019 | $38,000 | -19.1% | 404 | -27.1% | 0.00% | – |
Q1 2019 | $47,000 | +56.7% | 554 | +4.1% | 0.00% | – |
Q4 2018 | $30,000 | -57.7% | 532 | -38.8% | 0.00% | – |
Q3 2018 | $71,000 | +294.4% | 869 | +61.2% | 0.00% | – |
Q2 2018 | $18,000 | +800.0% | 539 | +433.7% | 0.00% | – |
Q1 2018 | $2,000 | -50.0% | 101 | -21.1% | 0.00% | – |
Q4 2017 | $4,000 | -88.6% | 128 | -88.7% | 0.00% | – |
Q3 2017 | $35,000 | +1650.0% | 1,131 | +1613.6% | 0.00% | – |
Q2 2017 | $2,000 | -50.0% | 66 | -66.2% | 0.00% | – |
Q1 2017 | $4,000 | +300.0% | 195 | +375.6% | 0.00% | – |
Q4 2016 | $1,000 | – | 41 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |